In patients with Prader-Willi syndrome, DCCR is expected to reduce hyperphagia through activation of the adenosine triphosphate–sensitive potassium channels in the hypothalamus.

The FDA has approved the first therapy to address hyperphagia for children and adults aged 4 years and older with Prader-Willi syndrome, Soleno Therapeutics announced. Prader-Willi syndrome is a ...

The placebo-controlled open-label Phase III DESTINY PWS study (NCT03440814) enrolled 125 participants with Prader-Willi syndrome aged four years or younger.

In March this year, the US Food and Drug Administration (FDA) approved the therapy under the brand name Vykat XR for treating extreme hunger in Prader-Willi syndrome patients.

The FDA granted priority review for a new drug application for an intranasal oxytocin analogue to reduce hyperphagia and behavioral distress associated with Prader-Willi syndrome, according to an ...

Soleno Therapeutics’ Vykat XR is now FDA approved for treating hyperphagia, or excessive hunger, in patients with Prader-Willi syndrome. The once-daily pill is the first approved therapy for ...

Federal regulators are clearing a first-of-its-kind treatment for symptoms of a rare neurodevelopmental disorder that is characterized by insatiable hunger. The Food and Drug Administration approved a ...

Children with Prader–Willi syndrome (PWS) receive growth-hormone (GH) replacement therapy. Small studies suggested that GH administration might also benefit adults with PWS; however, GH has ...

There is no cure for Prader Willi Syndrome, but with a good diet and a lot of physical therapy, life can be easier. Despite being hungry all of the time, Heather’s goal is to see that Journey ...

When mice with Prader-Willi syndrome were treated with these small molecule drugs during infancy, they lived longer and had more normal growth. “Our findings suggest that G9a inhibitors may play a ...

Management of Prader-Willi Syndrome: A book edited by Merlin Butler, Phillip D.K. Lee, and Barbara Y. Whitman, that is endorsed by the Prader-Willi Syndrome Association as a comprehensive resources.

The Food and Drug Administration (FDA) has granted Orphan Drug designation to Tesomet (Saniona) for the treatment of Prader-Willi syndrome. Prader-Willi syndrome is a rare genetic disease ...